Arcutis Biotherapeutics (ARQT)
Healthcare · Biotechnology
2 members of Congress have disclosed 5 trades in Arcutis Biotherapeutics (ARQT) since 2023: 3 buys and 2 sales. The most recent was disclosed on Jun 8, 2026.
- Trades disclosed
- 5
- Members trading
- 2
- Buys / sells
- 3 / 2
- Reported value
- $5K–$75K
Keep following the company.
Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.
What else is happening at ARQT
All research →Company filings and public records connected to this stock, ordered by when they became public or were first observed.
ARQT: third_quarter 2026 lobbying report
Issues related to tariffs
Public: Oct 19, 2026, 6:10 PM EDTOriginal source ↗ARQT: third_quarter 2026 lobbying report
Issues related to tariffs
Public: Sep 17, 2026, 3:53 PM EDTOriginal source ↗
Who traded ARQT
- Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)2 buys · 1 sale21Jun 8, 2026
- Rep. Josh Gottheimer (D-NJ-5)1 buy · 1 sale11Oct 15, 2023
All trades
- Jun 8, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Arcutis Biotherapeutics ARQT
$1K–$15K · Traded May 29, 2026 · disclosed Jun 8, 2026
- Apr 7, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Arcutis Biotherapeutics ARQT
$1K–$15K · Traded Mar 3, 2026 · disclosed Apr 7, 2026
- Jan 12, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Sold (partial) Arcutis Biotherapeutics ARQT
$1K–$15K · Traded Dec 11, 2025 · disclosed Jan 12, 2026
- Oct 15, 2023$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Sold Arcutis Biotherapeutics ARQT
$1K–$15K · Traded Sep 15, 2023 · disclosed Oct 15, 2023 · Joint
- May 19, 2023$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Bought Arcutis Biotherapeutics ARQT
$1K–$15K · Traded Apr 17, 2023 · disclosed May 19, 2023 · Joint
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.